Oculus Innovative Sciences (Oculus IS), an anti-infective company, is primed and soon ready to launch its Microcyn® Technology system of wound care in the United States. Already widely marketed in Mexico, India, China, and all over Europe with 24 clinical trials completed where its wound care system achieved premier results in safety and efficacy, Oculus IS plans its appearance in the U.S. marketplace early 2009.

Founded in 1999 by Hoji Alimi, CEO/Chairman, Oculus IS met with the FDA in August and received approval to move forward with a pivotal clinical trial using its proprietary Microcyn® Technology. It is a system of care for wounds such as diabetic foot ulcers. These complications, according to the American Diabetes Association, can cost $8,000 to $17,000 to treat conventionally.

"While we will continue to dialogue with the FDA on the specifics of the pivotal trial designs," Alimi tells DOTmed News, "The agreements from this meeting permit us to move forward in our efforts to secure a pharmaceutical partner for this next phase of our U.S. clinical studies."
Alimi also says that the company's revenues are up 59 percent over the same quarter last year and the potential exists for wide use, such as for the Department of Defense. "There is a significant pull in the market for a proven antimicrobial product," he continues. "Approximately 100,000 amputations occur per year, and many limbs could be salvaged with effective therapy. Our product is a unique compound which is poured into the wound. It is safe as saline solution."

Microcyn® Technology has been shown to eradicate infection, including MRSA, and promote rapid wound healing. Though the system can induce a burning sensation, it occurs without introduction of antibiotics; so, the bacterial cells have no chance to mutate. The compound kills the bacteria and the solution assists in vasodilation, in which oxygen in the blood aids rapid healing. The company also makes a gel formula as an after-treatment product which soothes the skin and continues to encourage healing.

Oculus IS operates principally from Petaluma, CA and has offices in Europe, Japan, Latin America and the Netherlands.

More Voices